AVAH
Full HouseAveanna Healthcare Holdings Inc. · Healthcare · United States · $2.9B cap · $28.2M/day traded
$12.24 -6.5% · close 12 Nov · scored 13 Nov
Score down 1.3 since 12 Nov.
Full House: Strong business, sensible price, and the market agrees.
As of 13 Nov 2026, the MoatMap Score for Aveanna Healthcare Holdings Inc. (AVAH) is 90/100, ranked against 25,000+ stocks in 38 markets (Quality 67, Value 54, Momentum 72, each scored against its sector).
Does the score work? Each tenth of the ranking, tracked monthly. See the record →
ABOUT AVEANNA HEALTHCARE HOLDINGS INC.
Read
Aveanna Healthcare Holdings is a prominent U.S. provider of in-home care services, specializing in skilled nursing, therapy, and personal care for medically fragile pediatric and adult patients. The company capitalizes on the growing shift towards home-based care, offering a cost-effective alternative to institutional settings. Its extensive national network and focus on complex care cases establish it as a key player in this specialized and high-demand healthcare niche.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2027E | 2028E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.7B | 1.8B | 1.9B | 2.0B | 2.4B | 9.7% | 2.6B | 2.7B | 2.9B | 6.0% |
| EPS | -0.69 | -3.57 | -0.71 | -0.06 | 1.11 | — | 1.26 | 1.52 | 1.68 | 14.8% |
| Shares | 184.7M | 188.9M | 190.7M | 193.2M | 211.0M | +14.2% | 218.3M | — | — | — |
| Debt | 1.3B | 1.5B | 1.5B | 1.5B | 1.5B | 3.9% | 1.5B | — | — | — |
| Equity | 638.0M | -4.2M | -127.4M | -122.1M | 195.2M | -25.6% | — | — | — | — |
| Op CF | -11.3M | -48.4M | 22.7M | 32.6M | 125.9M | 135.6% | 168.2M | — | — | — |
| Inv CF | -681.8M | -25.3M | -8.8M | -6.3M | -22.3M | — | — | — | — | — |
| Fin CF | 586.3M | 62.4M | 10.8M | 14.0M | 5.4M | — | — | — | — | — |
Above its 200-day average and 17% below its 52-week high.
Swung more than 61% of stocks we rank over the past year (volatility 49% a year).
How this is worked out
The Price check reads only the chart, the price side of the Momentum score in words; it is not the MoatMap Score.
- Still falling: It set a new 52-week low in the last two weeks, after a deep fall.
- Finding a floor: It fell hard, but has set no new low for more than two weeks.
- Turning up: It has climbed off its low and is back above a rising 50-day average.
- In an uptrend (this stock): It is near its 52-week high and above its 200-day average.
- No clear trend: None of the above: no recent deep fall and no steady climb.
- No read yet: Not enough price history yet: it needs a year of trading.
In past US falls, waiting for Turning up cut the chance of another 20% drop from 42% to 33%. Returns were no better, and 33% of turns failed.
The exact rules
Still falling is a new 52-week low in the last two weeks, at least 25% below the high, with the low set after the high. Finding a floor is the same fall with no new low in the last two weeks. Turning up is 20 or more trading days without a new low, at least 10% off it, and back above a rising 50-day average. In an uptrend is above the 200-day average, with the 50-day average above the 200-day, and within 15% of the high. No clear trend is everything else. No read yet is under 252 trading days of history, or missing data. A new state shows once it has held for three trading days.
In 2,112 US drawdowns since 2001, buying while the price was still falling was followed by a further 20% drop 42% of the time. Waiting for a turn (the Turning up rule above) cut that to 33%, at about 7% higher prices and with no better returns. Part of that cut is simply not buying: 13% of falls never turned, and waiting kept those out. Among turns that were bought, 38% still fell another 20%, and 33% of turns were followed by a new low within six months. The benefit was largest in crashes such as 2008 and 2020.
What it measures: how much the price moved day to day over the past year, scaled to a yearly figure (annualised volatility) and ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.
What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.
Calm is not safe: a calm stock can still slide steadily.
Rules fixed before any data was fetched. Describes the chart, not a recommendation.
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of AVAH are excluded.
| Ticker | Company | Mkt Cap | Score |
|---|---|---|---|
| AVAH | Aveanna Healthcare Holdings Inc.(you) | $2.9B | 90 |
| GRDN | Guardian Pharmacy Services, Inc. | $2.5B | 88 |
| MD | Pediatrix Medical Group, Inc. | $2.4B | 93 |
| ADUS | Addus HomeCare Corporation | $2.3B | 95 |
| AMN | AMN Healthcare Services, Inc. | $1.9B | 94 |
| CON | Concentra Group Holdings Parent, Inc. | $5.0B | 86 |
| HCSG | Healthcare Services Group, Inc. | $1.7B | 95 |
| OPCH | Option Care Health, Inc. | $4.7B | 84 |
| CHE | Chemed Corporation | $6.7B | 90 |
| ARDT | Ardent Health, Inc. | $1.7B | 97 |
Peer medians: ROE -31.0% · P/E 26.3x · Gross margin 63.3%
Company Deep Dive
A 10,000-word report: the business and its segments, what management promised on earnings calls and whether it delivered, the competition, and how things could turn out.